金融时报:下一个“重磅炸弹”创新药或将来自中国

医药魔方
Dec 03

中国创新药的全球崛起正在受到国际社会的广泛关注。在麦肯锡、经济学人之后,国际知名媒体《金融时报》也在近日发文表示:中国制药企业已掀起从“快速追随者(fast-follower)”到“首创者(First mover)”转变的新浪潮。《金融时报》判断,经过多年投资周期、监管改革及供应链常态化的发展后,中国生物制药产业已具备全球运营规模,下一款重磅炸弹药物或许会在上海研发、在亚洲多地开展临床试验、在苏州...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10